SK44094A3 - Method and composition for determining the immunological activity of bioactive substances - Google Patents

Method and composition for determining the immunological activity of bioactive substances Download PDF

Info

Publication number
SK44094A3
SK44094A3 SK440-94A SK44094A SK44094A3 SK 44094 A3 SK44094 A3 SK 44094A3 SK 44094 A SK44094 A SK 44094A SK 44094 A3 SK44094 A3 SK 44094A3
Authority
SK
Slovakia
Prior art keywords
ttp
pbl
cultures
tested
cytokines
Prior art date
Application number
SK440-94A
Other languages
English (en)
Slovak (sk)
Inventor
Anna Inglot
Zofia Blach-Olszewska
Original Assignee
Torf Ets
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Torf Ets filed Critical Torf Ets
Publication of SK44094A3 publication Critical patent/SK44094A3/sk

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/02—Medicinal preparations containing materials or reaction products thereof with undetermined constitution from inanimate materials
    • A61K35/10—Peat; Amber; Turf; Humus

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
SK440-94A 1991-10-26 1992-09-28 Method and composition for determining the immunological activity of bioactive substances SK44094A3 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP91118269A EP0539610A1 (en) 1991-10-26 1991-10-26 Method and composition for determining the immunological activity of solutions containing active substances
PCT/EP1992/002228 WO1993008470A1 (en) 1991-10-26 1992-09-28 Method and composition for determining the immunological activity of bioactive substances

Publications (1)

Publication Number Publication Date
SK44094A3 true SK44094A3 (en) 1995-03-08

Family

ID=8207282

Family Applications (1)

Application Number Title Priority Date Filing Date
SK440-94A SK44094A3 (en) 1991-10-26 1992-09-28 Method and composition for determining the immunological activity of bioactive substances

Country Status (22)

Country Link
US (1) US5543300A (2)
EP (2) EP0539610A1 (2)
JP (1) JPH07500905A (2)
AT (1) ATE153763T1 (2)
AU (1) AU678343B2 (2)
BG (1) BG61705B1 (2)
CA (1) CA2122131A1 (2)
CZ (1) CZ100494A3 (2)
DE (3) DE539610T1 (2)
DK (1) DK0609255T3 (2)
ES (1) ES2061424T3 (2)
FI (1) FI941920L (2)
GR (3) GR930300100T1 (2)
HU (1) HU216863B (2)
LV (1) LV12140B (2)
NO (1) NO941444L (2)
PL (1) PL170592B1 (2)
RO (1) RO114837B1 (2)
RU (1) RU2125727C1 (2)
SG (1) SG72665A1 (2)
SK (1) SK44094A3 (2)
WO (1) WO1993008470A1 (2)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19615470A1 (de) * 1996-04-19 1997-10-23 Heinz Beinio Körperpflegemittel und Verfahren zu seiner Herstellung
AU5643299A (en) * 1998-09-23 2000-04-10 Enerkom (Proprietary) Limited Humic acid and its use in the treatment of various conditions
RU2180120C1 (ru) * 2000-07-05 2002-02-27 Научно-исследовательский институт детских инфекций Способ выявления цитокинов
GB0101973D0 (en) * 2001-01-25 2001-03-14 Statens Seruminstitut Improved in vitro diagnostic method of detecting a cell-mediated immune response
RU2226275C2 (ru) * 2002-04-15 2004-03-27 Научно-исследовательский и учебно-методический центр биомедицинских технологий ВИЛАР Способ определения цитотоксического эффекта и ростстимулирующей активности веществ для доклинических испытаний
DK1449535T3 (da) * 2003-02-18 2006-09-11 Clinique La Prairie Res Sa Præparater der omfatter fötalt hæmoglobin og bakterieendotoksin samt eventuelt fötale leverbestanddele
US7497947B2 (en) * 2004-04-14 2009-03-03 Embro Corporation Devices for water treatment
US7614340B2 (en) * 2007-02-09 2009-11-10 Honeywell International Inc. Composite piston housing for aircraft brakes
AU2012304640A1 (en) 2011-09-07 2014-03-13 Embro Corporation Use of moss to reduce disinfection by-products in water treated with disinfectants
US9795809B2 (en) 2013-12-23 2017-10-24 Embro Corporation Use of moss to improve dental health
US10058542B1 (en) 2014-09-12 2018-08-28 Thioredoxin Systems Ab Composition comprising selenazol or thiazolone derivatives and silver and method of treatment therewith

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH636448A5 (en) * 1977-05-06 1983-05-31 Horst Veith Process for the determination of the effect of substances on constituents of the blood for the detection of infectious and immunological processes and composition for carrying it out
NZ214400A (en) * 1985-12-02 1989-05-29 Univ Otago Detecting infection in ruminant including conducting assay of mononuclear cell function
EP0238851B1 (en) * 1986-02-19 1992-12-09 Imreg, Inc. A method and means of assaying an immune system
CA1299099C (en) * 1986-03-06 1992-04-21 Paul Richard Wood In vitro assay for detecting cell-mediated immune responses
US5096708A (en) * 1988-07-07 1992-03-17 Sven Gohla Medical preparation containing as active agent a component from thuja plants which comprises polysaccharides
DE529032T1 (de) * 1991-03-16 1993-11-25 Torf Ets Verfahren zur extraction von torf und apparat zur durchführung dieses verfahrens.

Also Published As

Publication number Publication date
RU94022481A (ru) 1996-09-27
DE69220078D1 (de) 1997-07-03
CZ100494A3 (en) 1994-11-16
GR3024457T3 (en) 1997-11-28
NO941444D0 (no) 1994-04-21
FI941920A7 (fi) 1994-04-25
FI941920A0 (fi) 1994-04-25
DE69220078T2 (de) 1997-12-04
EP0609255A1 (en) 1994-08-10
PL170592B1 (en) 1997-01-31
FI941920L (fi) 1994-04-25
HU9401185D0 (en) 1994-07-28
BG98720A (bg) 1995-07-28
HU216863B (hu) 1999-09-28
BG61705B1 (bg) 1998-03-31
RO114837B1 (ro) 1999-07-30
LV12140A (lv) 1998-09-20
ES2061424T1 (es) 1994-12-16
HK1002610A1 (en) 1998-09-04
GR940300077T1 (en) 1994-11-30
EP0539610A1 (en) 1993-05-05
WO1993008470A1 (en) 1993-04-29
DE539610T1 (de) 1993-12-16
HUT69990A (en) 1995-09-28
US5543300A (en) 1996-08-06
DK0609255T3 (da) 1997-12-22
CA2122131A1 (en) 1993-04-29
GR930300100T1 (2) 1993-10-29
AU2650992A (en) 1993-05-21
DE609255T1 (de) 1995-06-14
JPH07500905A (ja) 1995-01-26
AU678343B2 (en) 1997-05-29
SG72665A1 (en) 2000-05-23
LV12140B (lv) 1998-12-20
ES2061424T3 (es) 1997-10-01
ATE153763T1 (de) 1997-06-15
EP0609255B1 (en) 1997-05-28
NO941444L (no) 1994-06-16
RU2125727C1 (ru) 1999-01-27

Similar Documents

Publication Publication Date Title
Ytterberg et al. Serum interferon levels in patients with systemic lupus erythematosus
Arneborn et al. T-lymphocyte subpopulations in relation to immunosuppression in measles and varicella
Nahmias et al. Inhibitory effect of heparin on herpes simplex virus
Friedman et al. Stimulation of interferon production in human lymphocytes by mitogens
Koff et al. Neuroendocrine hormones suppress macrophage-mediated lysis of herpes simplex virus-infected cells.
Smith et al. Studies of an inhibitor of DNA synthesis and a nonspecific mitogen elaborated by human lymphoblasts
Cutts et al. Suppression of lymphoid cell function in vitro by inhibition of 3-hydroxy-3-methylglutaryl coenzyme A reductase by lovastatin
SK44094A3 (en) Method and composition for determining the immunological activity of bioactive substances
Torseth et al. Significance of local γ interferon in recurrent herpes simplex infection
Nathan Interferon-gamma and macrophage activation in cell-mediated immunity
Hill et al. Failure to demonstrate circulating interferon during incubation period and acute stage of transfusion-associated hepatitis
Torseth et al. β interferon produced by keratinocytes in human cutaneous infection with herpes simplex virus
US5707814A (en) CD8+ cell antiviral factor
Argov et al. Defective natural killing activity but retention of lymphocyte-mediated antibody-dependent cellular cytotoxicity in patients with the X-linked lymphoproliferative syndrome
JPH01110633A (ja) 肝細胞刺激因子
Turco et al. Comparison of the properties of antirickettsial activity and interferon in mouse lymphokines
Chadha et al. Interferons and interferon inhibitory activity in disease and therapy
Aboagye-Mathiesen et al. Production of interferons in human placental trophoblast subpopulations and their possible roles in pregnancy
Ingimarsson et al. Immune Reactions and Long‐Term Therapy with Human Leukocyte Interferon
EP0722337A1 (en) Cd8?+ cell antiviral factor
HK1002610B (en) Method and composition for determining the immunological activity of bioactive substances
CA2300792A1 (en) An agent for increasing chemokine production
Lueker et al. Decreased reactivity of lymphocytes in mixed-leukocyte culture from patients with rheumatic fever
Redding et al. Oral herpes simplex virus infection with cardiac transplantation
Mahafzah et al. Effect of Meclomen on production and action of human interferon alpha